Pharmerging Market Size, Share 2022

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Pharmerging Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmerging Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmerging Overall Market Size
2.1 Global Pharmerging Market Size: 2021 VS 2028
2.2 Global Pharmerging Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmerging Players in Global Market
3.2 Top Global Pharmerging Companies Ranked by Revenue
3.3 Global Pharmerging Revenue by Companies
3.4 Top 3 and Top 5 Pharmerging Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmerging Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmerging Players in Global Market
3.6.1 List of Global Tier 1 Pharmerging Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmerging Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pharmerging Market Size Markets, 2021 & 2028
4.1.2 Tier 1
4.1.3 Tier 2
4.1.4 Tier 3
4.2 By Type - Global Pharmerging Revenue & Forecasts
4.2.1 By Type - Global Pharmerging Revenue, 2017-2022
4.2.2 By Type - Global Pharmerging Revenue, 2023-2028
4.2.3 By Type - Global Pharmerging Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmerging Market Size, 2021 & 2028
5.1.2 Lung Cancer
5.1.3 Breast Cancer
5.1.4 Chronic Myeloid Leukemia
5.1.5 Lymphomas
5.1.6 Other
5.2 By Application - Global Pharmerging Revenue & Forecasts
5.2.1 By Application - Global Pharmerging Revenue, 2017-2022
5.2.2 By Application - Global Pharmerging Revenue, 2023-2028
5.2.3 By Application - Global Pharmerging Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pharmerging Market Size, 2021 & 2028
6.2 By Region - Global Pharmerging Revenue & Forecasts
6.2.1 By Region - Global Pharmerging Revenue, 2017-2022
6.2.2 By Region - Global Pharmerging Revenue, 2023-2028
6.2.3 By Region - Global Pharmerging Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmerging Revenue, 2017-2028
6.3.2 US Pharmerging Market Size, 2017-2028
6.3.3 Canada Pharmerging Market Size, 2017-2028
6.3.4 Mexico Pharmerging Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmerging Revenue, 2017-2028
6.4.2 Germany Pharmerging Market Size, 2017-2028
6.4.3 France Pharmerging Market Size, 2017-2028
6.4.4 U.K. Pharmerging Market Size, 2017-2028
6.4.5 Italy Pharmerging Market Size, 2017-2028
6.4.6 Russia Pharmerging Market Size, 2017-2028
6.4.7 Nordic Countries Pharmerging Market Size, 2017-2028
6.4.8 Benelux Pharmerging Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmerging Revenue, 2017-2028
6.5.2 China Pharmerging Market Size, 2017-2028
6.5.3 Japan Pharmerging Market Size, 2017-2028
6.5.4 South Korea Pharmerging Market Size, 2017-2028
6.5.5 Southeast Asia Pharmerging Market Size, 2017-2028
6.5.6 India Pharmerging Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmerging Revenue, 2017-2028
6.6.2 Brazil Pharmerging Market Size, 2017-2028
6.6.3 Argentina Pharmerging Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmerging Revenue, 2017-2028
6.7.2 Turkey Pharmerging Market Size, 2017-2028
6.7.3 Israel Pharmerging Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmerging Market Size, 2017-2028
6.7.5 UAE Pharmerging Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pharmerging Major Product Offerings
7.1.4 Pfizer Pharmerging Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Pharmerging Major Product Offerings
7.2.4 Sanofi Pharmerging Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Pharmerging Major Product Offerings
7.3.4 GlaxoSmithKline Pharmerging Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Pharmerging Major Product Offerings
7.4.4 AstraZeneca Pharmerging Revenue in Global Market (2017-2022)
7.4.5 AstraZeneca Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Pharmerging Major Product Offerings
7.5.4 Novartis Pharmerging Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Pharmerging Major Product Offerings
7.6.4 Johnson & Johnson Pharmerging Revenue in Global Market (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Corporate Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche Pharmerging Major Product Offerings
7.7.4 F. Hoffmann-La Roche Pharmerging Revenue in Global Market (2017-2022)
7.7.5 F. Hoffmann-La Roche Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Pharmerging Major Product Offerings
7.8.4 Eli Lilly Pharmerging Revenue in Global Market (2017-2022)
7.8.5 Eli Lilly Key News
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Corporate Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Pharmerging Major Product Offerings
7.9.4 Boehringer Ingelheim Pharmerging Revenue in Global Market (2017-2022)
7.9.5 Boehringer Ingelheim Key News
7.10 Novo Nordisk
7.10.1 Novo Nordisk Corporate Summary
7.10.2 Novo Nordisk Business Overview
7.10.3 Novo Nordisk Pharmerging Major Product Offerings
7.10.4 Novo Nordisk Pharmerging Revenue in Global Market (2017-2022)
7.10.5 Novo Nordisk Key News
7.11 AbbVie
7.11.1 AbbVie Corporate Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Pharmerging Major Product Offerings
7.11.4 AbbVie Pharmerging Revenue in Global Market (2017-2022)
7.11.5 AbbVie Key News
7.12 Sun Pharmaceutical
7.12.1 Sun Pharmaceutical Corporate Summary
7.12.2 Sun Pharmaceutical Business Overview
7.12.3 Sun Pharmaceutical Pharmerging Major Product Offerings
7.12.4 Sun Pharmaceutical Pharmerging Revenue in Global Market (2017-2022)
7.12.5 Sun Pharmaceutical Key News
7.13 Teva Pharmaceutical Industries
7.13.1 Teva Pharmaceutical Industries Corporate Summary
7.13.2 Teva Pharmaceutical Industries Business Overview
7.13.3 Teva Pharmaceutical Industries Pharmerging Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Pharmerging Revenue in Global Market (2017-2022)
7.13.5 Teva Pharmaceutical Industries Key News
7.14 Mitsubishi Tanabe Pharma
7.14.1 Mitsubishi Tanabe Pharma Corporate Summary
7.14.2 Mitsubishi Tanabe Pharma Business Overview
7.14.3 Mitsubishi Tanabe Pharma Pharmerging Major Product Offerings
7.14.4 Mitsubishi Tanabe Pharma Pharmerging Revenue in Global Market (2017-2022)
7.14.5 Mitsubishi Tanabe Pharma Key News
7.15 Bristol-Myers Squibb
7.15.1 Bristol-Myers Squibb Corporate Summary
7.15.2 Bristol-Myers Squibb Business Overview
7.15.3 Bristol-Myers Squibb Pharmerging Major Product Offerings
7.15.4 Bristol-Myers Squibb Pharmerging Revenue in Global Market (2017-2022)
7.15.5 Bristol-Myers Squibb Key News
7.16 Kyowa Hakko Kirin
7.16.1 Kyowa Hakko Kirin Corporate Summary
7.16.2 Kyowa Hakko Kirin Business Overview
7.16.3 Kyowa Hakko Kirin Pharmerging Major Product Offerings
7.16.4 Kyowa Hakko Kirin Pharmerging Revenue in Global Market (2017-2022)
7.16.5 Kyowa Hakko Kirin Key News
7.17 CSL Behring
7.17.1 CSL Behring Corporate Summary
7.17.2 CSL Behring Business Overview
7.17.3 CSL Behring Pharmerging Major Product Offerings
7.17.4 CSL Behring Pharmerging Revenue in Global Market (2017-2022)
7.17.5 CSL Behring Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Pharmerging Major Product Offerings
7.18.4 Takeda Pharmerging Revenue in Global Market (2017-2022)
7.18.5 Takeda Key News
7.19 Amgen
7.19.1 Amgen Corporate Summary
7.19.2 Amgen Business Overview
7.19.3 Amgen Pharmerging Major Product Offerings
7.19.4 Amgen Pharmerging Revenue in Global Market (2017-2022)
7.19.5 Amgen Key News
7.20 Bayer
7.20.1 Bayer Corporate Summary
7.20.2 Bayer Business Overview
7.20.3 Bayer Pharmerging Major Product Offerings
7.20.4 Bayer Pharmerging Revenue in Global Market (2017-2022)
7.20.5 Bayer Key News
7.21 Biogen
7.21.1 Biogen Corporate Summary
7.21.2 Biogen Business Overview
7.21.3 Biogen Pharmerging Major Product Offerings
7.21.4 Biogen Pharmerging Revenue in Global Market (2017-2022)
7.21.5 Biogen Key News
7.22 Eisai
7.22.1 Eisai Corporate Summary
7.22.2 Eisai Business Overview
7.22.3 Eisai Pharmerging Major Product Offerings
7.22.4 Eisai Pharmerging Revenue in Global Market (2017-2022)
7.22.5 Eisai Key News
7.23 Daiichi Sankyo
7.23.1 Daiichi Sankyo Corporate Summary
7.23.2 Daiichi Sankyo Business Overview
7.23.3 Daiichi Sankyo Pharmerging Major Product Offerings
7.23.4 Daiichi Sankyo Pharmerging Revenue in Global Market (2017-2022)
7.23.5 Daiichi Sankyo Key News
7.24 Dainippon Sumitomo Pharma
7.24.1 Dainippon Sumitomo Pharma Corporate Summary
7.24.2 Dainippon Sumitomo Pharma Business Overview
7.24.3 Dainippon Sumitomo Pharma Pharmerging Major Product Offerings
7.24.4 Dainippon Sumitomo Pharma Pharmerging Revenue in Global Market (2017-2022)
7.24.5 Dainippon Sumitomo Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Pharmerging Market Opportunities & Trends in Global Market
Table 2. Pharmerging Market Drivers in Global Market
Table 3. Pharmerging Market Restraints in Global Market
Table 4. Key Players of Pharmerging in Global Market
Table 5. Top Pharmerging Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmerging Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmerging Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmerging Product Type
Table 9. List of Global Tier 1 Pharmerging Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmerging Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pharmerging Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmerging Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmerging Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Pharmerging Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmerging Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmerging Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Pharmerging Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmerging Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmerging Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmerging Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmerging Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmerging Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmerging Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmerging Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmerging Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmerging Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmerging Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmerging Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmerging Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Pharmerging Product Offerings
Table 32. Pfizer Pharmerging Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Pharmerging Product Offerings
Table 35. Sanofi Pharmerging Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Pharmerging Product Offerings
Table 38. GlaxoSmithKline Pharmerging Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Pharmerging Product Offerings
Table 41. AstraZeneca Pharmerging Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Pharmerging Product Offerings
Table 44. Novartis Pharmerging Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Pharmerging Product Offerings
Table 47. Johnson & Johnson Pharmerging Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann-La Roche Corporate Summary
Table 49. F. Hoffmann-La Roche Pharmerging Product Offerings
Table 50. F. Hoffmann-La Roche Pharmerging Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly Corporate Summary
Table 52. Eli Lilly Pharmerging Product Offerings
Table 53. Eli Lilly Pharmerging Revenue (US$, Mn), (2017-2022)
Table 54. Boehringer Ingelheim Corporate Summary
Table 55. Boehringer Ingelheim Pharmerging Product Offerings
Table 56. Boehringer Ingelheim Pharmerging Revenue (US$, Mn), (2017-2022)
Table 57. Novo Nordisk Corporate Summary
Table 58. Novo Nordisk Pharmerging Product Offerings
Table 59. Novo Nordisk Pharmerging Revenue (US$, Mn), (2017-2022)
Table 60. AbbVie Corporate Summary
Table 61. AbbVie Pharmerging Product Offerings
Table 62. AbbVie Pharmerging Revenue (US$, Mn), (2017-2022)
Table 63. Sun Pharmaceutical Corporate Summary
Table 64. Sun Pharmaceutical Pharmerging Product Offerings
Table 65. Sun Pharmaceutical Pharmerging Revenue (US$, Mn), (2017-2022)
Table 66. Teva Pharmaceutical Industries Corporate Summary
Table 67. Teva Pharmaceutical Industries Pharmerging Product Offerings
Table 68. Teva Pharmaceutical Industries Pharmerging Revenue (US$, Mn), (2017-2022)
Table 69. Mitsubishi Tanabe Pharma Corporate Summary
Table 70. Mitsubishi Tanabe Pharma Pharmerging Product Offerings
Table 71. Mitsubishi Tanabe Pharma Pharmerging Revenue (US$, Mn), (2017-2022)
Table 72. Bristol-Myers Squibb Corporate Summary
Table 73. Bristol-Myers Squibb Pharmerging Product Offerings
Table 74. Bristol-Myers Squibb Pharmerging Revenue (US$, Mn), (2017-2022)
Table 75. Kyowa Hakko Kirin Corporate Summary
Table 76. Kyowa Hakko Kirin Pharmerging Product Offerings
Table 77. Kyowa Hakko Kirin Pharmerging Revenue (US$, Mn), (2017-2022)
Table 78. CSL Behring Corporate Summary
Table 79. CSL Behring Pharmerging Product Offerings
Table 80. CSL Behring Pharmerging Revenue (US$, Mn), (2017-2022)
Table 81. Takeda Corporate Summary
Table 82. Takeda Pharmerging Product Offerings
Table 83. Takeda Pharmerging Revenue (US$, Mn), (2017-2022)
Table 84. Amgen Corporate Summary
Table 85. Amgen Pharmerging Product Offerings
Table 86. Amgen Pharmerging Revenue (US$, Mn), (2017-2022)
Table 87. Bayer Corporate Summary
Table 88. Bayer Pharmerging Product Offerings
Table 89. Bayer Pharmerging Revenue (US$, Mn), (2017-2022)
Table 90. Biogen Corporate Summary
Table 91. Biogen Pharmerging Product Offerings
Table 92. Biogen Pharmerging Revenue (US$, Mn), (2017-2022)
Table 93. Eisai Corporate Summary
Table 94. Eisai Pharmerging Product Offerings
Table 95. Eisai Pharmerging Revenue (US$, Mn), (2017-2022)
Table 96. Daiichi Sankyo Corporate Summary
Table 97. Daiichi Sankyo Pharmerging Product Offerings
Table 98. Daiichi Sankyo Pharmerging Revenue (US$, Mn), (2017-2022)
Table 99. Dainippon Sumitomo Pharma Corporate Summary
Table 100. Dainippon Sumitomo Pharma Pharmerging Product Offerings
Table 101. Dainippon Sumitomo Pharma Pharmerging Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Pharmerging Segment by Type in 2021
Figure 2. Pharmerging Segment by Application in 2021
Figure 3. Global Pharmerging Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmerging Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmerging Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmerging Revenue in 2021
Figure 8. By Type - Global Pharmerging Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmerging Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmerging Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmerging Revenue Market Share, 2017-2028
Figure 12. US Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmerging Revenue Market Share, 2017-2028
Figure 16. Germany Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmerging Revenue Market Share, 2017-2028
Figure 24. China Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmerging Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmerging Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmerging Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann-La Roche Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Boehringer Ingelheim Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novo Nordisk Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AbbVie Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sun Pharmaceutical Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Teva Pharmaceutical Industries Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Mitsubishi Tanabe Pharma Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Bristol-Myers Squibb Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Kyowa Hakko Kirin Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. CSL Behring Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Takeda Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Amgen Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Bayer Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Biogen Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Eisai Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Daiichi Sankyo Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Dainippon Sumitomo Pharma Pharmerging Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

DOWNLOAD SAMPLE